Folefac Aminkeng

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Journal: Pharmacogenomics

Published: August 11, 2026

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.

Journal: Cancers

Published: March 30, 2023

An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.

An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.

Journal: Clinical pharmacology and therapeutics

Published: December 22, 2022

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer.

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer.

Journal: Thoracic cancer

Published: July 01, 2022

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature.

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature.

Journal: Frontiers in immunology

Published: November 02, 2021

Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.

Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients.

Journal: International journal of cancer

Published: April 17, 2021

Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study.

Neutrophil-to-Lymphocyte Ratio Predicts Development of Immune-Related Adverse Events and Outcomes from Immune Checkpoint Blockade: A Case-Control Study.

Journal: Cancers

Published: February 22, 2021

Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.

Unbiased Profiling of Isogenic Huntington Disease hPSC-Derived CNS and Peripheral Cells Reveals Strong Cell-Type Specificity of CAG Length Effects.

Journal: Cell reports

Published: September 07, 2017

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.

Journal: PloS one

Published: June 11, 2017

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines.

Journal: Pediatric blood & cancer

Published: May 30, 2017

The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.

The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.

Journal: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

Published: May 30, 2017

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.

Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer.

Journal: JAMA oncology

Published: April 28, 2017

Showing 1-12 of 32

Last Updated: 09/26/2026